Ramdev in trouble! SC rebuke leads to ban of 14 Patanjali Ayurved products, deets inside

Livogrit, Eyegrit Gold, Patanjali Drishti Eye Drops are among the Divya Pharmacy items that are prohibited.

Follow us:

X/Reddif/Canva

The Uttarakhand government has also given Patanjali a setback following the Supreme Court's censure. The Uttarakhand Drug Control Department's licensing body has prohibited 14 goods from Patanjali's Divya Pharmacy. Due to deceptive advertising, Divya Pharmacy's products are no longer permitted. Shwasari Gold, Shwasari Vati, Divya Broncom, Shwasari Pravahi, Shwasari Avaleha, Mukta Vati Extra Power, Lipidom, BP Grit, Madhugrit, Madhunashini Vati Extra Power, Livamrit Advance, Livogrit, Eyegrit Gold, and Patanjali Drishti Eye Drops are among the Divya Pharmacy items that have been prohibited.

Patanjali
Patanjali in trouble!  X

The medical association stops rudimentary actions!

Dr. RV Ashokan, the president of the Indian Medical Association, stated earlier today that we brought Patanjali to court because Swami Ramdev had gone too far. He disparaged contemporary medical research and declared he could treat COVID-19 with coronal. Ashokan claimed that Ramdev insulted medical science by claiming that "modern medicine is a stupid science" in an interview with the media.

Asokan claimed that Ramdev disregarded the medical community when he asserted that "modern medicine is a stupid and bankrupt science," in an interview. The IMA filed a 2022 petition with the Supreme Court, claiming that the COVID immunization campaign and contemporary medical systems are the targets of a smear campaign. 

This is where the trouble began!

"Allopathy is a foolish science and medicines such as Remdesivir, Fabiflu, and other drugs approved by the Drugs Controller General of India have failed to treat COVID-19 patients," allegedly stated Ramdev in a 2021 video. His comments sparked intense indignation, and the IMA served him with a legal notice.Last month, the court ordered Patanjali Ayurved Ltd., Ramdev, and his assistant Acharya Balakrishnan to apologise in public for disobeying its directives over deceptive advertisements.

The Indian Medical Association, the petitioner, was also strongly criticized by the court during a hearing on April 23, when it was stated that some of its members also recommend costly and useless medications. It referred to multiple charges that the IMA had engaged in unethical behavior.